Breast Cancer Clinical Trial

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin’s Disease

Summary

The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.

View Full Description

Full Description

The screening breast MRI and mammography will be performed 6 months or longer after the last mammogram. For pre-menopausal women, the screening will be performed during the second week of the menstrual cycle to reduce cycle-related breast changes. As much as possible, the breast MRI and mammogram are to be performed on the same day.
On the day of the breast imaging studies, the patient will also be asked to fill out a baseline breast health questionnaire, which includes questions on time since radiation therapy, prior screening history, history of prior benign breast biopsies, menopausal status, prior hormonal therapy use, etc.
In patients with suspicious findings or findings highly suggestive of malignancy, the abnormal findings will be reviewed with the patient and recommendations will be made for a biopsy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female patients treated with radiation therapy to the chest area for Hodgkin's disease
Age between 12 and 35 at initial treatment
Eight years or longer after initial treatment
Pre-approval from the participant's insurance company for the breast imaging studies

Exclusion Criteria:

Pregnant or lactating women
Post Bilateral mastectomy
Currently undergoing breast cancer therapy
Known metastatic cancer
Patients with contraindications for undergoing an MRI: cardiac pacemaker, known metallic objects in body e.g. metallic clips, bullets, shrapnel or buckshots.

Study is for people with:

Breast Cancer

Estimated Enrollment:

148

Study ID:

NCT00165412

Recruitment Status:

Completed

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Brigham and Women's Hospital
Boston Massachusetts, 02115, United States
Dana-Farber Cancer Center
Boston Massachusetts, 02115, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

148

Study ID:

NCT00165412

Recruitment Status:

Completed

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider